Boston Scientific (BSX) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Boston Scientific (BSX) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance

Boston Scientific (BSX) PT Lowered to $105 at Piper Sandler, 'Buy The Dip'

February 4, 2026 9:46 AM EST

(Updated - February 4, 2026 9:52 AM EST)

Piper Sandler analyst Matt O\'Brien lowered the price target on Boston Scientific (NYSE: BSX) to $105.00 (from $120.00) while maintaining a Overweight rating.

"Q4 Beat But Key Drivers Deceleration to Weight on Stock; Buy The Dip"... More